Protocol for prophylaxis of venous thromboembolism in varicose vein surgery of the lower limbs.
Marcos Arêas MarquesStenio Karlos Alvim FiorellBernardo Cunha Senra BarrosAlcides José Araújo RibeiroArno von Buettner RistowRossano Kepler Alvim FiorelliPublished in: Revista do Colegio Brasileiro de Cirurgioes (2022)
Pulmonary embolism is the most feared complication of venous thromboembolism (VTE) and the third leading cause of cardiovascular mortality in the world, after acute myocardial infarction and stroke. The risk of VTE is virtually universal in hospitalized patients, especially those with reduced mobility. Although variable in incidence between clinical and surgical patients, up to 66.6% of events related to hospitalizations can occur after discharge, with this risk remaining for up to 90 days. Despite all the investment made in VTE prophylaxis in recent decades, there is still no consensus or specific guidelines for its prevention in patients undergoing conventional surgery for varicose veins of lower limbs. The adoption of a validated risk assessment model for VTE prophylaxis, based on the current literature, may help in the implementation and standardization of VTE prophylaxis in conventional lower limb varicose vein surgery, in addition to this benefit, it may lead to a reduction in the length of hospital stay and the number of readmissions.
Keyphrases
- venous thromboembolism
- pulmonary embolism
- minimally invasive
- direct oral anticoagulants
- coronary artery bypass
- lower limb
- acute myocardial infarction
- risk assessment
- patients undergoing
- inferior vena cava
- surgical site infection
- healthcare
- systematic review
- risk factors
- percutaneous coronary intervention
- primary care
- randomized controlled trial
- atrial fibrillation
- type diabetes
- coronary artery disease
- heavy metals
- human health
- brain injury
- cardiovascular disease
- acute coronary syndrome
- quality improvement
- blood brain barrier